The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa
Open Access
- 4 March 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (3) , e9538
Abstract
Although loss to follow-up after antiretroviral therapy (ART) initiation is increasingly recognized, little is known about pre-treatment losses to care (PTLC) after an initial positive HIV test. Our objective was to determine PTLC in newly identified HIV-infected individuals in South Africa. We assembled the South African Test, Identify and Link (STIAL) Cohort of persons presenting for HIV testing at two sites offering HIV and CD4 count testing and HIV care in Durban, South Africa. We defined PTLC as failure to have a CD4 count within 8 weeks of HIV diagnosis. We performed multivariate analysis to identify factors associated with PTLC. From November 2006 to May 2007, of 712 persons who underwent HIV testing and received their test result, 454 (64%) were HIV-positive. Of those, 206 (45%) had PTLC. Infected patients were significantly more likely to have PTLC if they lived ≥10 kilometers from the testing center (RR = 1.37; 95% CI: 1.11–1.71), had a history of tuberculosis treatment (RR = 1.26; 95% CI: 1.00–1.58), or were referred for testing by a health care provider rather than self-referred (RR = 1.61; 95% CI: 1.22–2.13). Patients with one, two or three of these risks for PTLC were 1.88, 2.50 and 3.84 times more likely to have PTLC compared to those with no risk factors. Nearly half of HIV-infected persons at two high prevalence sites in Durban, South Africa, failed to have CD4 counts following HIV diagnosis. These high rates of pre-treatment loss to care highlight the urgent need to improve rates of linkage to HIV care after an initial positive HIV test.Keywords
This publication has 15 references indexed in Scilit:
- Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in UgandaBMC Public Health, 2009
- Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, ZambiaAIDS Care, 2008
- Overestimates of Survival after HAART: Implications for Global Scale-Up EffortsPLOS ONE, 2008
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2007
- True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi2007
- Risk factors for treatment denial and loss to follow‐up in an antiretroviral treatment cohort in KenyaTropical Medicine & International Health, 2007
- Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program EvaluationClinical Infectious Diseases, 2006
- Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western KenyaAIDS, 2006